AdverseEvent.ai
This page presents data from the FDA Adverse Event Reporting System (FAERS) and the FDA-approved drug label. A report submitted to FAERS does not prove a drug caused the reported event. Always consult a healthcare provider about medications.

Hydrocortisone (hydrocortisone lotion)

corticosteroid
Last updated: June 21, 2026
Preview tracking

Hydrocortisone is the brand name for hydrocortisone lotion, a corticosteroid. According to the FDA-approved label, Hydrocortisone Lotion is indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses. FAERS contains 65,091 submissions naming this drug from 2001 through 2026; the top three reactions cited are off label use, drug ineffective, and fatigue.

Most-Reported Reactions

Counts of the reactions most often cited in FAERS submissions that named Hydrocortisone. Inclusion here does not establish causation - submitters describe what was observed, not what was confirmed. One submission can list several reactions, so the totals exceed the report count.

OFF LABEL USE 9,164 (14.1%) DRUG INEFFECTIVE 7,258 (11.2%) FATIGUE 5,734 (8.8%) CONDITION AGGRAVATED 5,323 (8.2%) NAUSEA 4,844 (7.4%) RASH 4,746 (7.3%) DIARRHOEA 4,331 (6.7%) PAIN 4,322 (6.6%) HEADACHE 4,308 (6.6%) ARTHRALGIA 4,153 (6.4%) DYSPNOEA 4,146 (6.4%) PYREXIA 3,869 (5.9%) VOMITING 3,795 (5.8%) PRURITUS 3,550 (5.5%) MALAISE 3,521 (5.4%)

Patient Demographics

Patient sex and age across the FAERS submissions that named Hydrocortisone. Percentages here are computed only from submissions where these fields were filled in - many leave them blank.

By Sex

Female Male Unknown

By Age Group

0-17 18-44 45-64 65+

Severity Outcomes

Severity flags recorded across the 65,091 FAERS submissions that named Hydrocortisone. Each bar shows the count of those reports carrying that flag. A single case can carry more than one (a hospitalization that became life-threatening, for example), so these bars are independent rates - they don't sum to 100%. Inclusion of a case under any flag does not establish that the drug caused the outcome.

DEATH 9,462 (14.5%) HOSPITALIZATION 27,762 (42.7%) LIFE-THREATENING 8,335 (12.8%) DISABLING 5,324 (8.2%)

Submissions Per Quarter

Quarterly count of FAERS submissions that named Hydrocortisone. Ups and downs on this chart can track prescribing volume, news cycles, or shifts in how reports get filed, rather than the drug becoming safer or more dangerous.

2001 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026

From the FDA-Approved Label

Excerpts from the official FDA-approved prescribing information for Hydrocortisone. This is the authoritative source on indications, warnings, and known adverse reactions.

Indications

Hydrocortisone Lotion is indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses.

Adverse Reactions (from label)

The following local adverse reactions are reported infrequently with topical corticosteroids, but may occur more frequently with the use of occlusive dressings. These reactions are listed in an aproximate decreasing order of occurrence: burning, itching, irritation, dryness, folliculitis, hypertrichosis, acneiform eruptions, hypopigmentation, perioral dermitis, allergic contact dermatis, maceration of the skin, secondary infection, skin atrophy, striae, and miliaria. To report SUSPECTED ADVERSE REACTIONS, contact Allegis Holdings, LLC at 1-866-633-9033 or FDA at 1-800-FDA-1088 or https://fda.gov/Safety/MedWatch/

FDA label effective date: 2026-01-08

Disclaimer

AdverseEvent.ai is not affiliated with the FDA. Adverse-event counts come from the FDA Adverse Event Reporting System (FAERS). Drug labels come from the FDA drug label dataset. A report submitted to FAERS does not prove a drug caused the reported event — always consult a healthcare provider about medications. This site is for informational purposes only and is not medical advice.